The impact rapid weight loss can have on muscle mass
Aug. 21
There are concerns that the increased use of new weight loss and diabetes medications like Wegovy, Ozempic, Zepbound and Mounjaro are leading to significant loss of muscle mass. Some doctors are worried that people are becoming sarcopenic (low muscle mass) and are at higher risk for frailty with the increasing use of these medications to achieve very low weights or BMIs.
Dr. Amit Shah, who works in the Department of Internal Medicine at Mayo Clinic Arizona, joined Arizona Horizon to discuss some of the risks.
In this segment:
Also in this episode:
SPOTLIGHT
STAY in touch
with azpbs.org!
Subscribe to Arizona PBS Newsletters:
Aug. 22
Drug price cuts begin
Aug. 21
The state of housing in Arizona
Aug. 21
Grass to Xeriscape: What is it?
